76 results
8-K
EX-99.1
LSTA
Lisata Therapeutics Inc
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
, an industry leader and expert in preventative cardiology and lipidology, is the Founder and Chief Scientific Officer of Corvidia Therapeutics, which … and Chief Executive Officer of Caladrius.
In addition to his current roles, Dr. Davidson is a nationally recognized expert in lipidology and has been
8-K
EX-99.1
LSTA
Lisata Therapeutics Inc
5 Jun 03
Other events
12:00am
of directors.
"We are delighted to announce the appointment of Wayne Marasco, a
distinguished scientist and leading expert in AIDS and cancer research
8-K
EX-99.1
LSTA
Lisata Therapeutics Inc
12 Jun 09
Departure of Directors or Certain Officers
12:00am
Exhibit 99.1
NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman
8-K
LSTA
Lisata Therapeutics Inc
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
of the Board.
Dr. Davidson is a nationally recognized expert in lipidology and has been named one of "The Best Doctors in America" by Best Doctors
8-K
EX-99.2
LSTA
Lisata Therapeutics Inc
20 Nov 06
Departure of Directors or Principal Officers
12:00am
(ASCs)
for autologous use, announced today that it has appointed Steven S. Myers, an
expert in competitive business procurement and management
8-K
EX-99.2
5d1akxfawmyqquimhetn
11 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
0fq0xq8i85d
11 Jun 10
Other Events
12:00am
425
fwf7 gkd303
27 Apr 22
Business combination disclosure
5:26pm
8-K
EX-99.3
7t3xd2mao645
15 Aug 12
Results of Operations and Financial Condition
12:00am
8-K
0xcszctg84nwmnkf9k
14 Apr 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
o36iwpz oq
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am